Trends and determinants of peripartum blood transfusions

BACKGROUND: Blood transfusion is critical in mitigating blood loss during delivery, but the epidemiology of peripartum blood transfusion in the United States is not fully understood. The objective of this study was to estimate trends in peripartum blood transfusions, including severe hemorrhage, and identify transfusion risk factors. STUDY DESIGN AND METHODS: A retrospective cohort was assembled from the Recipient Epidemiology and Donor Study IV Pediatric (REDS-IV-P) database, which includes a network of hospitals and blood centers across four U.S. regional hubs. This included in-hospital deliveries ≥24 weeks gestation from 2019 to 2024, with the outcome being any peripartum (within ±7 days of delivery) blood product transfusion. Bayesian Model Averaging (BMA) was used to examine associations. RESULTS: There were 158,322 deliveries, with transfusion occurring in 4246 (11% were severe hemorrhage). Overall incidence of transfusion increased from ~2% early in the study period to ~3% in later years (p < 0.001). The odds of peripartum transfusion were higher for deliveries where patients had an underlying hemoglobinopathy (adjusted odds ratio [aOR] [95% confidence interval; CI] aOR = 3.35 [2.65, 4.24]), venous thromboembolism (aOR = 3.25 [2.47, 4.26]), received hemostatic factor (aOR = 10.30 [9.58, 11.06]), mechanical ventilation (aOR = 13.91 [8.76, 22.11]), or hysterectomy (aOR = 13.68 [9.86, 18.96]). CONCLUSION: Peripartum transfusions are increasing across the REDS-IV-P hubs and are associated with underlying medical-obstetric risk factors such as bleeding disorders and hemoglobinopathies. Our findings support the importance of early prenatal healthcare and identification of conditions that may help prevent peripartum hemorrhage and associated transfusions.

Authors

Institutions

Publication Details

Journal
Transfusion
Published
2026-11-01
DOI
https://doi.org/10.1111/trf.70475
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends and determinants of peripartum blood transfusions

Cassandra D. Josephson, Jeffrey J. VanWormer, Robert Andrew Desimone, Alan E. Mast et al.
Transfusion
Blood transfusion and management
article

Trends and determinants of peripartum blood transfusions

Cassandra D. Josephson, Jeffrey J. VanWormer, Robert Andrew Desimone, Alan E. Mast, David L. McClure, Sarah E. Reese, Jennifer Jury McIntosh, Brian Custer, Nareg H. Roubinian, Bryan R. Spencer, Moeun Son, Martha C. Sola-Visner, Lisa Baumann Kreuziger, Jeanne E. Hendrickson, Eldad A. Hod, Rebecca Jeffries Birch, Naomi L.C. Luban, Paul M. Ness, for the NHLBI Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric (REDS‐IV‐P)
article en

Abstract

BACKGROUND: Blood transfusion is critical in mitigating blood loss during delivery, but the epidemiology of peripartum blood transfusion in the United States is not fully understood. The objective of this study was to estimate trends in peripartum blood transfusions, including severe hemorrhage, and identify transfusion risk factors. STUDY DESIGN AND METHODS: A retrospective cohort was assembled from the Recipient Epidemiology and Donor Study IV Pediatric (REDS-IV-P) database, which includes a network of hospitals and blood centers across four U.S. regional hubs. This included in-hospital deliveries ≥24 weeks gestation from 2019 to 2024, with the outcome being any peripartum (within ±7 days of delivery) blood product transfusion. Bayesian Model Averaging (BMA) was used to examine associations. RESULTS: There were 158,322 deliveries, with transfusion occurring in 4246 (11% were severe hemorrhage). Overall incidence of transfusion increased from ~2% early in the study period to ~3% in later years (p < 0.001). The odds of peripartum transfusion were higher for deliveries where patients had an underlying hemoglobinopathy (adjusted odds ratio [aOR] [95% confidence interval; CI] aOR = 3.35 [2.65, 4.24]), venous thromboembolism (aOR = 3.25 [2.47, 4.26]), received hemostatic factor (aOR = 10.30 [9.58, 11.06]), mechanical ventilation (aOR = 13.91 [8.76, 22.11]), or hysterectomy (aOR = 13.68 [9.86, 18.96]). CONCLUSION: Peripartum transfusions are increasing across the REDS-IV-P hubs and are associated with underlying medical-obstetric risk factors such as bleeding disorders and hemoglobinopathies. Our findings support the importance of early prenatal healthcare and identification of conditions that may help prevent peripartum hemorrhage and associated transfusions.

Transfusion
Westat (United States) (US), Children's National (US), NewYork–Presbyterian Hospital (US), American Red Cross (US), Harvard University (US), Johns Hopkins University (US), Emory University (US), University of California, San Francisco (US), George Washington University (US), Medical College of Wisconsin (US), Columbia University Irving Medical Center (US), Yale University (US), Johns Hopkins All Children's Hospital (US), Weill Cornell Medicine (US), Vitalant Research Institute (US), Marshfield Clinic Research Foundation (US), Marshfield Clinic Research Institute (US), Weill Cornell Medical Center (US), Kaiser Permanente Northern California (US)
Openalex Percentile: Top 14%
Blood transfusion and management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon